LLY Eli Lilly and CoWatchlist
About Eli Lilly and Co Company
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
FDA Grants Second Conditional Approval For Eli Lilly's Rare Blood Cancer Drug
Friday, the FDA approved Eli Lilly and Co's (NYSE: LLY) Jaypirca (pirtobrutinib, 100 mg & 50 mg tablets) for adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) wh
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs
Roche Holding AG (OTC:RHHBY) has agreed to acquire a privately held obesity company Carmot Therapeutics, seeking to challenge the dominance of weight-loss drugs from Novo Nordisk A/S (NYSE:NVO) and El
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 15, 2023
Eli Lilly and Company (NYSE: LLY) today announced the extension of the expiration of the tender offer to acquire all of the issued and outstanding...
Pfizer discontinues its twice-daily experimental weight loss pill due to high rates of adverse side effects.
The pill showed significant weight loss in patients but faced low tolerance in a mid-stage clinical study.
Phase two trial data for a once-a-day version of the drug expected in the first half of 2024.
Pfizer's shares fell 4% in premarket trading after announcing the trial results.
The discontinuation ma...